IndexIQ Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $406K | Sell |
8,196
-1,922
| -19% | -$95.2K | 0.01% | 595 |
|
|
2021
Q4 | $515K | Sell |
10,118
-653
| -6% | -$33.2K | 0.02% | 543 |
|
|
2021
Q3 | $601K | Buy |
10,771
+1,079
| +11% | +$60.2K | 0.02% | 438 |
|
|
2021
Q2 | $415K | Sell |
9,692
-83
| -0.8% | -$3.55K | 0.01% | 650 |
|
|
2021
Q1 | $408K | Buy |
+9,775
| New | +$408K | 0.01% | 544 |
|
|
2020
Q1 | – | Sell |
-16,065
| Closed | -$965K | – | 1147 |
|
|
2019
Q4 | $965K | Sell |
16,065
-5,098
| -24% | -$306K | 0.03% | 277 |
|
|
2019
Q3 | $1.2M | Sell |
21,163
-3,967
| -16% | -$224K | 0.04% | 276 |
|
|
2019
Q2 | $1.4M | Sell |
25,130
-6,452
| -20% | -$359K | 0.04% | 255 |
|
|
2019
Q1 | $1.6M | Buy |
+31,582
| New | +$1.6M | 0.05% | 243 |
|